Literature DB >> 30980112

The deubiquitinase OTUD5 regulates Ku80 stability and non-homologous end joining.

Fangzhou Li1, Qianqian Sun1, Kun Liu1, Haichao Han1, Ning Lin1, Zhongyi Cheng2, Yueming Cai3, Feng Tian4, Zebin Mao1, Tanjun Tong1, Wenhui Zhao5.   

Abstract

The ability of cells to repair DNA double-strand breaks (DSBs) is important for maintaining genome stability and eliminating oncogenic DNA lesions. Two distinct and complementary pathways, non-homologous end joining (NHEJ) and homologous recombination (HR), are employed by mammalian cells to repair DNA DSBs. Each pathway is tightly controlled in response to increased DSBs. The Ku heterodimer has been shown to play a regulatory role in NHEJ repair. Ku80 ubiquitination contributes to the selection of a DSB repair pathway by causing the removal of Ku heterodimers from DSB sites. However, whether Ku80 deubiquitination also plays a role in regulating DSB repair is unknown. To address this question, we performed a comprehensive study of the deubiquitinase specific for Ku80, and our study showed that the deubiquitinase OTUD5 serves as an important regulator of NHEJ repair by increasing the stability of Ku80. Further studies revealed that OTUD5 depletion impaired NHEJ repair, and hence reduced overall DSB repair. Furthermore, OTUD5-depleted cells displayed excess end resection; as a result, HR repair was facilitated by OTUD5 depletion during the S/G2 phase. In summary, our study demonstrates that OTUD5 is a specific deubiquitinase for Ku80 and establishes OTUD5 as an important and positive regulator of NHEJ repair.

Entities:  

Keywords:  DNA damage response; DNA lesion; DUBA; Deubiquitinases library; XRCC5

Mesh:

Substances:

Year:  2019        PMID: 30980112     DOI: 10.1007/s00018-019-03094-5

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  39 in total

1.  XRCC3 promotes homology-directed repair of DNA damage in mammalian cells.

Authors:  A J Pierce; R D Johnson; L H Thompson; M Jasin
Journal:  Genes Dev       Date:  1999-10-15       Impact factor: 11.361

2.  Ku DNA end-binding protein modulates homologous repair of double-strand breaks in mammalian cells.

Authors:  A J Pierce; P Hu; M Han; N Ellis; M Jasin
Journal:  Genes Dev       Date:  2001-12-15       Impact factor: 11.361

3.  Interplay between human DNA repair proteins at a unique double-strand break in vivo.

Authors:  Amélie Rodrigue; Matthieu Lafrance; Marie-Christine Gauthier; Darin McDonald; Michael Hendzel; Stephen C West; Maria Jasin; Jean-Yves Masson
Journal:  EMBO J       Date:  2006-01-05       Impact factor: 11.598

Review 4.  A genomic and functional inventory of deubiquitinating enzymes.

Authors:  Sebastian M B Nijman; Mark P A Luna-Vargas; Arno Velds; Thijn R Brummelkamp; Annette M G Dirac; Titia K Sixma; René Bernards
Journal:  Cell       Date:  2005-12-02       Impact factor: 41.582

Review 5.  The mechanism of human nonhomologous DNA end joining.

Authors:  Michael R Lieber
Journal:  J Biol Chem       Date:  2007-11-12       Impact factor: 5.157

Review 6.  Mechanism of eukaryotic homologous recombination.

Authors:  Joseph San Filippo; Patrick Sung; Hannah Klein
Journal:  Annu Rev Biochem       Date:  2008       Impact factor: 23.643

Review 7.  DNA double-strand breaks: signaling, repair and the cancer connection.

Authors:  K K Khanna; S P Jackson
Journal:  Nat Genet       Date:  2001-03       Impact factor: 38.330

8.  Analysis of ku80-mutant mice and cells with deficient levels of p53.

Authors:  D S Lim; H Vogel; D M Willerford; A T Sands; K A Platt; P Hasty
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

9.  DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation.

Authors:  M J Difilippantonio; J Zhu; H T Chen; E Meffre; M C Nussenzweig; E E Max; T Ried; A Nussenzweig
Journal:  Nature       Date:  2000-03-30       Impact factor: 49.962

10.  Recruitment and dissociation of nonhomologous end joining proteins at a DNA double-strand break in Saccharomyces cerevisiae.

Authors:  Dongliang Wu; Leana M Topper; Thomas E Wilson
Journal:  Genetics       Date:  2008-02-03       Impact factor: 4.562

View more
  6 in total

1.  Deubiquitinase OTUD6A promotes breast cancer progression by increasing TopBP1 stability and rendering tumor cells resistant to DNA-damaging therapy.

Authors:  Yan Zhao; Xinping Huang; Dan Zhu; Min Wei; Jiechen Luo; Shuyu Yu; Yonglu Tian; Xiaofeng Zheng
Journal:  Cell Death Differ       Date:  2022-06-29       Impact factor: 15.828

2.  Characterization of Double-Strand Break Repair Protein Ku80 Location Within the Murine Retina.

Authors:  Brigitte Müller; Franziska Serafin; Leonie Luise Laucke; Wilhelm Rheinhard; Tobias Wimmer; Knut Stieger
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-06-01       Impact factor: 4.925

Review 3.  Double-Stranded Break Repair in Mammalian Cells and Precise Genome Editing.

Authors:  Akhtar Ali; Wei Xiao; Masroor Ellahi Babar; Yanzhen Bi
Journal:  Genes (Basel)       Date:  2022-04-22       Impact factor: 4.141

4.  A ubiquitin variant-based affinity approach selectively identifies substrates of the ubiquitin ligase E6AP in complex with HPV-11 E6 or HPV-16 E6.

Authors:  Felix A Ebner; Carolin Sailer; Daniela Eichbichler; Jasmin Jansen; Anna Sladewska-Marquardt; Florian Stengel; Martin Scheffner
Journal:  J Biol Chem       Date:  2020-08-27       Impact factor: 5.157

5.  Deubiquitinase OTUD5 modulates mTORC1 signaling to promote bladder cancer progression.

Authors:  Tao Hou; Weichao Dan; Tianjie Liu; Bo Liu; Yi Wei; Chenyang Yue; Taotao Que; Bohan Ma; Yuzeshi Lei; Zixi Wang; Jin Zeng; Yizeng Fan; Lei Li
Journal:  Cell Death Dis       Date:  2022-09-09       Impact factor: 9.685

6.  Deubiquitinase OTUD5 is a positive regulator of mTORC1 and mTORC2 signaling pathways.

Authors:  Jin Hwa Cho; Kidae Kim; Sung Ah Kim; Sungryul Park; Bi-Oh Park; Jong-Hwan Kim; Seon-Young Kim; Min Jee Kwon; Myeong Hoon Han; Sung Bae Lee; Byoung Chul Park; Sung Goo Park; Jeong-Hoon Kim; Sunhong Kim
Journal:  Cell Death Differ       Date:  2020-10-27       Impact factor: 15.828

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.